Driven by personal loss, a graduate student and his mentors unveil the mysteries of CFTR mutations, seeking to unlock new treatments for cystic fibrosis patients who currently resist available drugs.

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it. In a study of 591 women with early stage breast cancer who completed five years of endocrine therapy, 47% decided to continue the treatment.

In a new publication in PLOS Digital Health, experts in bioethics and law call for immediate standardization of methods for collection of race and ethnicity data, and for developers to warranty race and ethnicity data quality in medical AI systems. The research synthesizes concerns about why patient race data in EHRs may not be accurate, identifies best practices for healthcare systems and medical AI researchers to improve data accuracy, and provides a new template for medical AI developers to transparently warrant the quality of their race and ethnicity data